Cartesian Therapeutics (RNAC) Prepaid Assets (2015 - 2026)

Cartesian Therapeutics (RNAC) has reported Prepaid Assets for 12 consecutive years, with $3.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Prepaid Assets rose 7.39% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (up 7.39% YoY), while the FY2025 annual figure was $3.0 million, down 3.88% from the prior year.
• Prepaid Assets climbed to $3.1 million in Q1 2026 per RNAC's latest filing, from $3.0 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $6.5 million in Q2 2022 and bottomed at $2.0 million in Q2 2024.
• Historically, Prepaid Assets has averaged $3.9 million across 5 years, with a median of $3.5 million in 2023.
• Annual changes were most pronounced in 2024 — Prepaid Assets plunged 52.0% — and 2025, when it soared 32.93%.
• Cartesian Therapeutics' Prepaid Assets stood at $3.8 million in 2022, then surged by 31.47% to $5.0 million in 2023, then plunged by 36.7% to $3.1 million in 2024, then fell by 3.88% to $3.0 million in 2025, then climbed by 3.81% to $3.1 million in 2026.
• Business Quant data shows RNAC's Prepaid Assets at $3.1 million in Q1 2026, $3.0 million in Q4 2025, and $3.2 million in Q3 2025.